<add><doc>
	<field name = "DATE">9-APR-1987 16:52:22.24</field>
	<field name = "PLACES">usa</field>
	<field name = "titulo">SMITHKLINE SKB> VACCINE GETS APPROVAL OVERSEAS</field>
	<field name = "DATELINE">PHILADELPHIA, April 9 -</field>
	<field name = "content">Smithkline Beckman Corp said its
genetically engineered hepatitis B vaccine has received
regulatory approval for marketing in Switzerland and
Luxembourg.
    The vaccine, called Engerix-B, has been approved in several
other countries, including Belgium and Hong Kong.
    Smithkline said it is currently considering marketing
avenues in the United States.
    Merck and Co MRK> also has a genetically engineered
vaccine being marketed in several foreign markets, according to
industry sources.
 Reuter</field>
</doc></add>
